328 related articles for article (PubMed ID: 28134792)
1. From Immunologically Archaic to Neoteric Glycovaccines.
Cavallari M; De Libero G
Vaccines (Basel); 2017 Jan; 5(1):. PubMed ID: 28134792
[TBL] [Abstract][Full Text] [Related]
2. Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?
Jakobsen H; Jonsdottir I
Scand J Immunol; 2003 Aug; 58(2):119-28. PubMed ID: 12869132
[TBL] [Abstract][Full Text] [Related]
3. Vaccines against polysaccharide antigens.
Lesinski GB; Westerink MA
Curr Drug Targets Infect Disord; 2001 Nov; 1(3):325-34. PubMed ID: 12455405
[TBL] [Abstract][Full Text] [Related]
4. Polysaccharide conjugate vaccine protein carriers as a "neglected valency" - Potential and limitations.
Bröker M; Berti F; Schneider J; Vojtek I
Vaccine; 2017 Jun; 35(25):3286-3294. PubMed ID: 28487056
[TBL] [Abstract][Full Text] [Related]
5. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
6. Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines.
Käyhty H
Biologicals; 1994 Dec; 22(4):397-402. PubMed ID: 7779368
[TBL] [Abstract][Full Text] [Related]
7. Bacterial polysaccharides as vaccines--immunity and chemical characterization.
Lee CJ; Lee LH; Lu CS; Wu A
Adv Exp Med Biol; 2001; 491():453-71. PubMed ID: 14533815
[TBL] [Abstract][Full Text] [Related]
8. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
[TBL] [Abstract][Full Text] [Related]
9. [Conjugated vaccines].
Fritzell B
Therapie; 2005; 60(3):249-55. PubMed ID: 16128267
[TBL] [Abstract][Full Text] [Related]
10. Bacterial capsular polysaccharides--biochemistry, immunity and vaccine.
Lee CJ
Mol Immunol; 1987 Oct; 24(10):1005-19. PubMed ID: 3119993
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.
Marshall GS; Marchant CD; Blatter M; Friedland LR; Aris E; Miller JM
Hum Vaccin; 2011 Feb; 7(2):258-64. PubMed ID: 21307655
[TBL] [Abstract][Full Text] [Related]
12. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
Blanchard-Rohner G; Pollard AJ
Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal conjugate vaccine for young children.
Selman S; Hayes D; Perin LA; Hayes WS
Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
[TBL] [Abstract][Full Text] [Related]
14. [Invasive pneumococcal disease in two non-vaccinated pediatric cases: pleural empyema and bacteremia].
Kanık Yüksek S; Gülhan B; Tezer H; Özkaya Parlakay A; Uzun Kenan B; Sayed Oskovi H; Nar Ötgün S
Mikrobiyol Bul; 2015 Jul; 49(3):446-53. PubMed ID: 26313286
[TBL] [Abstract][Full Text] [Related]
15. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
[TBL] [Abstract][Full Text] [Related]
16. Intranasal Immunization with the Commensal
Shekhar S; Khan R; Schenck K; Petersen FC
Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
[No Abstract] [Full Text] [Related]
17. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT.
Parkkali T; Käyhty H; Ruutu T; Volin L; Eskola J; Ruutu P
Bone Marrow Transplant; 1996 Nov; 18(5):961-7. PubMed ID: 8932852
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in bacterial conjugate vaccines.
Goldblatt D
J Med Microbiol; 1998 Jul; 47(7):563-7. PubMed ID: 9839559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
